DIPHENHYDRAMINE HCL, ZINC ACETATE

N/A

Manufactured by Bionpharma Inc.

124 FDA adverse event reports analyzed

Last updated: 2026-04-15

About DIPHENHYDRAMINE HCL, ZINC ACETATE

DIPHENHYDRAMINE HCL, ZINC ACETATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Bionpharma Inc.. The most commonly reported adverse reactions for DIPHENHYDRAMINE HCL, ZINC ACETATE include HEADACHE, DIARRHOEA, DIZZINESS, FATIGUE, PRURITUS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DIPHENHYDRAMINE HCL, ZINC ACETATE.

Top Adverse Reactions

HEADACHE4 reports
DIARRHOEA3 reports
DIZZINESS3 reports
FATIGUE3 reports
PRURITUS3 reports
RASH3 reports
SKIN HAEMORRHAGE3 reports
VOMITING3 reports
ABDOMINAL DISCOMFORT2 reports
ABDOMINAL PAIN UPPER2 reports
BLOOD PRESSURE DECREASED2 reports
DRUG INEFFECTIVE2 reports
DRY SKIN2 reports
ECZEMA2 reports
EPISTAXIS2 reports
ERYTHEMA2 reports
LABORATORY TEST ABNORMAL2 reports
NAUSEA2 reports
PRESYNCOPE2 reports
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION2 reports
ACCIDENTAL EXPOSURE TO PRODUCT1 reports
ANISOCORIA1 reports
ANXIETY1 reports
ARTHRALGIA1 reports
ARTHRITIS1 reports
BACK DISORDER1 reports
BACK PAIN1 reports
CELLULITIS1 reports
CHILLS1 reports
CHOLECYSTECTOMY1 reports
CLAVICLE FRACTURE1 reports
CONDITION AGGRAVATED1 reports
COUGH1 reports
DEPRESSION1 reports
DERMATITIS ATOPIC1 reports
DRUG HYPERSENSITIVITY1 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION1 reports
EXPOSURE VIA SKIN CONTACT1 reports
FALL1 reports
FEELING ABNORMAL1 reports
FLUSHING1 reports
FUNGAL INFECTION1 reports
GAIT DISTURBANCE1 reports
GAIT INABILITY1 reports
HAEMATOCRIT INCREASED1 reports
HAEMOGLOBIN INCREASED1 reports
HAEMORRHOIDS1 reports
HYPOKINESIA1 reports
ILLNESS1 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION1 reports
INCORRECT DOSE ADMINISTERED1 reports
INFLUENZA LIKE ILLNESS1 reports
INJECTION SITE BRUISING1 reports
INJECTION SITE ERYTHEMA1 reports
INJECTION SITE PAIN1 reports
INJECTION SITE RASH1 reports
INJECTION SITE SWELLING1 reports
INJECTION SITE VESICLES1 reports
INJURY ASSOCIATED WITH DEVICE1 reports
IRRITABILITY1 reports
LACRIMATION INCREASED1 reports
LIMB DISCOMFORT1 reports
MEMORY IMPAIRMENT1 reports
MIOSIS1 reports
MUSCLE SWELLING1 reports
MYALGIA1 reports
NASOPHARYNGITIS1 reports
NECK PAIN1 reports
OCULAR DISCOMFORT1 reports
PAIN IN JAW1 reports
PARAINFLUENZAE VIRUS INFECTION1 reports
PERIPHERAL SWELLING1 reports
PHOTOSENSITIVITY REACTION1 reports
PNEUMONIA1 reports
PRODUCT PREPARATION ERROR1 reports
PRODUCT USE IN UNAPPROVED INDICATION1 reports
PSORIASIS1 reports
RED BLOOD CELL COUNT DECREASED1 reports
RETCHING1 reports
SCRATCH1 reports
SKIN EXFOLIATION1 reports
SKIN FISSURES1 reports
SLUGGISHNESS1 reports
STRESS1 reports
SUICIDAL IDEATION1 reports
THERAPEUTIC PRODUCT EFFECT DELAYED1 reports
THERAPEUTIC RESPONSE DECREASED1 reports
THERAPY NON RESPONDER1 reports
VISION BLURRED1 reports
WEIGHT DECREASED1 reports
WEIGHT FLUCTUATION1 reports
WHITE MATTER LESION1 reports
WOUND1 reports
WRONG TECHNIQUE IN DEVICE USAGE PROCESS1 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS1 reports

Report Outcomes

Out of 14 classified reports for DIPHENHYDRAMINE HCL, ZINC ACETATE:

Serious 21.4%Non-Serious 78.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female10 (71.4%)
Male4 (28.6%)

Reports by Age

Age 782 reports
Age 401 reports
Age 541 reports
Age 571 reports
Age 621 reports
Age 721 reports
Age 801 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with DIPHENHYDRAMINE HCL, ZINC ACETATE?

This profile reflects 124 FDA FAERS reports that mention DIPHENHYDRAMINE HCL, ZINC ACETATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for DIPHENHYDRAMINE HCL, ZINC ACETATE?

Frequently reported terms in FAERS include HEADACHE, DIARRHOEA, DIZZINESS, FATIGUE, PRURITUS, RASH. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures DIPHENHYDRAMINE HCL, ZINC ACETATE?

Labeling and FAERS entries often list Bionpharma Inc. in connection with DIPHENHYDRAMINE HCL, ZINC ACETATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.